The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion by 2035, while Europe is expected to expand from USD 7.02 Billion to USD 10.98 Billion, supported by increasing COPD diagnosis, combination therapies, biologics, and digital respiratory care adoption.
The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion by 2035, while Europe is expected to expand from USD 7.02 Billion to USD 10.98 Billion, supported by increasing COPD diagnosis, combination therapies, biologics, and digital respiratory care adoption.